Both in Pharmaceuticals
Oruka Therapeutics vs Rhythm Pharmaceuticals
Over the past year ORKA returned +269.7% and RYTM returned +5.4%; their daily moves had a correlation of 0.24.
ORKA +269.7% RYTM +5.4%Growth of $1, one year, split-adjusted
| Metric | ORKA | RYTM |
|---|---|---|
| Price | $101.41 | $110.68 |
| Market cap | $6.71B | $7.62B |
| Today | +1.87% | +28.04% |
| 1 month | +26.5% | +21.9% |
| 6 months | +45.3% | +14.6% |
| Year to date | +234.6% | +3.4% |
| 1 year | +287.2% | −2.7% |
| Revenue growth (YoY) | — | +46.9% |
| Gross margin | — | 87.5% |
| Net margin | — | −70.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 31.8× |
| Net cash | $873.6M | $224.8M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 61.5% |
| Short % of float | 11.5% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).